# Children using social media at younger age more likely to try drugs, study finds – K24 Digital > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/children-using-social-media-at-younger-age-more-likely-to-try-drugs-study-finds-k24-digital/ > **Published:** 2026-06-14T17:16:03-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:52:41-04:00 > **Clinical Summary:** Social media cannabis use in adolescents increases initiation risk. Clinical screening and digital literacy guidance for early intervention. --- ✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. ResearchPolicyMental HealthPediatricsSafetyAnxietyNeurology Why This Matters Clinicians should screen pediatric patients for early social media use and cannabis attitudes, as early adoption correlates with increased drug experimentation risk. Understanding this association helps providers identify vulnerable youth who may benefit from preventive counseling and family-based interventions before substance use begins. This evidence supports integrating digital media habits and substance use expectancies into routine [adolescent health](https://cedclinic.com/adolescent-cannabis-use-sexual-behavior-study/) assessments. Clinical Summary A study using the Adolescent Brain Cognitive Development Study cohort found that early social media use in children is associated with increased likelihood of drug experimentation, including [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), mediated in part by developing positive attitudes toward cannabis effects. The research suggests that social media exposure during formative years may shape adolescents’ perceptions of cannabis as beneficial or harmless, potentially lowering the threshold for trial and continued use. This finding has important implications for clinicians conducting substance use screening and counseling with adolescents, as it identifies a modifiable environmental factor (social media consumption) that influences cannabis initiation risk. Understanding the pathway between social media engagement, attitude formation, and drug use behavior can inform preventive conversations with families about [media literacy](https://cedclinic.com/power-of-clicks-and-likes/) and the curated nature of online content regarding substances. Clinicians should consider inquiring about adolescent social media use patterns during preventive health visits and discuss how algorithmically driven content can shape perceptions of [cannabis safety](https://cedclinic.com/respiratory-effects-inhalational-marijuana/) or efficacy, particularly given the prevalence of cannabis promotion on digital platforms. Dr. Caplan’s Take “This observational finding from the ABCD cohort is important for our awareness but doesn’t establish causation, and I’d want to see whether early social media use itself drives cannabis attitudes or whether other factors—peer environment, family dynamics, underlying risk profiles—are doing the heavy lifting. What this does tell us is that we need to screen adolescents thoughtfully for their media exposure and cannabis perceptions during routine visits, because the window for prevention and honest conversation is real, even if the mechanism here isn’t yet clear.” Clinical Perspective 🧠 While this finding from the ABCD Study highlights a concerning association between early social media use and subsequent drug initiation in adolescents, clinicians should recognize that the pathway from social media exposure to [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) likely involves multiple interconnected factors including peer influence, developmental stage, family dynamics, and underlying mental health conditions rather than social media alone. The study’s reliance on observational data means we cannot definitively establish causation, and it remains unclear whether social media drives pro-cannabis attitudes, whether adolescents already inclined toward substance use seek out such content, or whether both reflect a shared underlying vulnerability. Additionally, the relationship between positive cannabis perceptions and actual use differs by age, socioeconomic status, and access, creating a complex clinical picture that extends beyond individual behavior modification. In practice, this research suggests that routine adolescent screening should incorporate questions about social media engagement and exposure to drug-related content, providing an opportunity to discuss realistic harms 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Children%20using%20social%20media%20at%20younger%20age%20more%20likely%20to%20try%20drugs%2C%20study%20finds%20-%20K24%20Digital%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D59099)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D59099)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Children%20using%20social%20media%20at%20younger%20age%20more%20likely%20to%20try%20drugs%2C%20study%20finds%20-%20K24%20Digital%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D59099)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [Cannabis, Tics, Tourette Syndrome, and OCD Symptoms](https://cedclinic.com/cannabinoids-for-tic-disorders-ocd/) - [Study: NY cannabis packaging law did not reduce child ingestions – Healio](https://cedclinic.com/child-resistant-packaging-cannabis-study-ny/) - [Clearing the Haze: Cannabis Use in Pregnancy and Long-Term Outcomes – MotherToBaby](https://cedclinic.com/cannabis-use-pregnancy-risks-clearing-the-haze/) 📰 Source: [https://k24.digital/lifestyle/technology/children-using-social-media-at-younger-age-more-likely-to-try-drugs-study-finds](https://k24.digital/lifestyle/technology/children-using-social-media-at-younger-age-more-likely-to-try-drugs-study-finds) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).